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Background
Gliomas are neoplasm of the central nervous system and
make up approximately 80% of all malignant brain
tumors. Even with the advancement in the field of surgery,
chemotherapy and radiotherapy, the prognosis of glioma
patients is dismal. Many molecular alterations of various
oncogenes and tumor suppressor genes are seen in glioma
and can be used for molecular characterization of tumor.
The Bmi1 is a Polycomb group of protein which is asso-
ciated with various cancers. The main alterations in Bmi1
gene in glioma includes copy number variation, over
expression of mRNA and protein levels when compared to
the non glioma brain samples. The CDKN2A (p16) is a
tumor suppressor gene, mapped to 9p21. Alterations of
the 9p21 locus have been implicated in many types of can-
cer, indicating the role of the tumor suppressor genes
CDKN2A which encodes for p16INK4a/p14ARF. In this
study we wanted to check the gene expression pattern of
p16 and Bmi1 genes in glioma and their clinical
correlations.
Material and methods
50 glioma tissues were collected from Neurosurgery
department and histologically confirmed as glioma.
Total RNA was isolated and 1µg was converted to
cDNA using RT kit. Real time RT PCR was performed
using Taqman probes specific for p16 and Bmi1 and
GAPDH as internal control.
Results
We showed that the p16 mRNA levels in glioma found
to be decreased when compared to the non glioma
tissues. Bmi1 gene was found to be over expressed in
glioma. There is a correlation in the expression of both
genes. Bmi1 is the main upstream regulator of p16 and
we found that gene expressions of both are correlated in
glioma.
Conclusions
It is concluded that p16 and Bmi1 genes are important
in glioma and can be used as independent biomarker in
glioma characterisation.
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